Global Medical REIT Inc.
GMRENYSEReal Estate
$35.74
$-0.45(-1.24%)
Market Cap$478125610
P/E Ratio—
52W High$45.75
52W Low$29.05
Global Medical REIT Inc. (GMRE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GMRE · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 25, 2026EPS Actual
$1.10
Est. $0.07 · +1592.3%
Revenue
$0.04B
Est. $0.04B · -6.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 25, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 5-Quarter EPS Beat Streak
GMRE reports quarterly as a NYSE-listed REIT - Healthcare Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 25, 2026 | $0.07 | $1.10 | +1592.3% | $0.04B | $0.04B | -6.1% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $1.05 | $1.12 | +6.7% | $0.04B | $0.04B | +8.3% |
| — Q3 FY2025 | Aug 5, 2025 | $1.15 | $1.15 | +0.0% | $0.04B | $0.04B | +14.7% |
| — Q2 FY2025 | May 7, 2025 | $0.22 | $0.22 | +0.0% | $0.03B | $0.04B | -2.4% |
| ▲ Q1 FY2025 | Feb 27, 2025 | $0.01 | $0.22 | +2100.0% | $0.03B | $0.03B | +0.2% |
| ▼ Q4 FY2024 | Nov 6, 2024 | $0.23 | $0.22 | -4.3% | $0.03B | $0.03B | -2.3% |
| — Q3 FY2024 | Aug 6, 2024 | $0.22 | $0.22 | +0.0% | $0.04B | $0.03B | +12.3% |
| ▼ Q2 FY2024 | May 7, 2024 | $0.24 | $0.23 | -4.2% | $0.04B | $0.03B | +2.6% |
Q1 FY2026
Feb 25, 2026Beat
EPS Actual
$1.10
EPS Est.
$0.07
EPS Surpr.
+1592.3%
Revenue
$0.04B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$1.12
EPS Est.
$1.05
EPS Surpr.
+6.7%
Revenue
$0.04B
Q3 FY2025
Aug 5, 2025
EPS Actual
$1.15
EPS Est.
$1.15
EPS Surpr.
+0.0%
Revenue
$0.04B
Q2 FY2025
May 7, 2025
EPS Actual
$0.22
EPS Est.
$0.22
EPS Surpr.
+0.0%
Revenue
$0.03B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
$0.22
EPS Est.
$0.01
EPS Surpr.
+2100.0%
Revenue
$0.03B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
$0.22
EPS Est.
$0.23
EPS Surpr.
-4.3%
Revenue
$0.03B
Q3 FY2024
Aug 6, 2024
EPS Actual
$0.22
EPS Est.
$0.22
EPS Surpr.
+0.0%
Revenue
$0.04B
Q2 FY2024
May 7, 2024Miss
EPS Actual
$0.23
EPS Est.
$0.24
EPS Surpr.
-4.2%
Revenue
$0.04B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q2 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q1 FY2027 | $0.15 | $0.15 | $0.15 | 1 |
| Q4 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 25, 2026 | +1592.3% | $36.24 | $37.20 | +2.65% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +6.7% | $30.46 | $30.15 | -1.02% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +0.0% | $33.45 | $33.75 | +0.90% |
| ▲ Q2 FY2025 | May 7, 2025 | +0.0% | $38.60 | $38.45 | -0.39% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +2100.0% | $42.45 | $42.40 | -0.12% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -4.3% | $46.10 | $46.25 | +0.33% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +0.0% | $45.40 | $46.30 | +1.98% |
| ▼ Q2 FY2024 | May 7, 2024 | -4.2% | $42.40 | $42.35 | -0.12% |
Q1 FY2026+2.65%
Report Date
Feb 25, 2026
EPS Beat/Miss
+1592.3%
Price Before
$36.24
Price After
$37.20
Q4 FY2025-1.02%
Report Date
Nov 4, 2025
EPS Beat/Miss
+6.7%
Price Before
$30.46
Price After
$30.15
Q3 FY2025+0.90%
Report Date
Aug 5, 2025
EPS Beat/Miss
+0.0%
Price Before
$33.45
Price After
$33.75
Q2 FY2025-0.39%
Report Date
May 7, 2025
EPS Beat/Miss
+0.0%
Price Before
$38.60
Price After
$38.45
Q1 FY2025-0.12%
Report Date
Feb 27, 2025
EPS Beat/Miss
+2100.0%
Price Before
$42.45
Price After
$42.40
Q4 FY2024+0.33%
Report Date
Nov 6, 2024
EPS Beat/Miss
-4.3%
Price Before
$46.10
Price After
$46.25
Q3 FY2024+1.98%
Report Date
Aug 6, 2024
EPS Beat/Miss
+0.0%
Price Before
$45.40
Price After
$46.30
Q2 FY2024-0.12%
Report Date
May 7, 2024
EPS Beat/Miss
-4.2%
Price Before
$42.40
Price After
$42.35
Avg Beat Reaction+0.67%
Avg Miss Reaction+0.11%
Beat Rate6 / 8 quarters
Largest Move+2.65% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GMRE ends December
Global Medical REIT Inc. (GMRE) most recently reported earnings on February 25, 2026 for Q1 FY2026, posting EPS of $1.10 — beating the analyst consensus of $0.07 by +1592.3%. GMRE has beaten EPS estimates for 5 consecutive quarters. The next GMRE earnings date is expected around September 1, 2026.
Each quarter, investors track GMRE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GMRE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GMRE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GMRE earnings · 5 questionsGlobal Medical REIT Inc.'s next earnings report is expected around September 1, 2026. GMRE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GMRE historically reports after market close (AMC).
GMRE earnings datewhen is GMRE earningsGMRE next earnings datewhen does GMRE report earningsGMRE earnings calendar
▸ Source: FMP · Global Medical REIT Inc. SEC filings · US GAAP · Global Medical REIT Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026